We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERAS icon
5426
Erasca
ERAS
$6.82B
$437K ﹤0.01%
+20,590
New +$425K
KRNL
5427
CALL
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$437K ﹤0.01%
741,062
+329,063
+80% +$3.19M
TILE icon
5428
Interface
TILE
$2.19B
$436K ﹤0.01%
28,780
-237,475
-89% -$3.42M
OWLT.WS
5429
CALL
DELISTED
Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
OWLT.WS
$436K ﹤0.01%
+464,229
New +$474K
ABTX
5430
DELISTED
Allegiance Bancshares
ABTX
$435K ﹤0.01%
11,393
+3,134
+38% +$115K
GLDD
5431
DELISTED
Great Lakes Dredge & Dock
GLDD
$434K ﹤0.01%
28,772
-113,791
-80% -$1.69M
SCZ icon
5432
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$434K ﹤0.01%
+5,828
New +$444K
SLRC icon
5433
SLR Investment Corp
SLRC
$681M
$433K ﹤0.01%
22,622
+9,975
+79% +$190K
GTPBW
5434
CALL
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$433K ﹤0.01%
360,987
+123,987
+52% +$164K
STXB
5435
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$432K ﹤0.01%
17,862
-5,420
-23% -$125K
TEF
5436
DELISTED
Telefonica
TEF
$430K ﹤0.01%
97,771
+69,484
+246% +$309K
RETA
5437
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$429K ﹤0.01%
+4,263
New +$500K
CNNB
5438
DELISTED
CINCINNATI BANCORP
CNNB
$429K ﹤0.01%
28,743
+1,384
+5% +$20K
AUBN icon
5439
Auburn National Bancorp
AUBN
$91.7M
$428K ﹤0.01%
12,579
-12,512
-50% -$430K
UTL icon
5440
Unitil
UTL
$975M
$428K ﹤0.01%
+10,000
New +$500K
CAMP
5441
DELISTED
CalAmp Corp.
CAMP
$428K ﹤0.01%
1,869
+1,109
+146% +$293K
BSBK icon
5442
Bogota Financial
BSBK
$116M
$427K ﹤0.01%
41,255
-11,846
-22% -$122K
GNLN icon
5443
Greenlane Holdings
GNLN
$1.92M
0
PZN
5444
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$427K ﹤0.01%
43,443
+20,504
+89% +$220K
PROF
5445
Profound Medical
PROF
$254M
$426K ﹤0.01%
+29,107
New +$443K
BARK.WS
5446
CALL
DELISTED
BARK Inc Warrants
BARK.WS
$425K ﹤0.01%
250,000
LVTX
5447
DELISTED
LAVA Therapeutics
LVTX
$425K ﹤0.01%
71,833
-66,998
-48% -$482K
EVOP
5448
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$425K ﹤0.01%
17,928
+638
+4% +$16.9K
ELVN icon
5449
Enliven Therapeutics
ELVN
$4.43B
$424K ﹤0.01%
25,951
+17,235
+198% +$358K
ARQQ icon
5450
CALL
Arqit Quantum
ARQQ
$373M
$423K ﹤0.01%
+8,248
New +$4.1M

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.